Share Name Share Symbol Market Type Share ISIN Share Description
Phorm Corp LSE:PHRM London Ordinary Share SG9999009278 ORD NPV (DI)
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 1.00 0.00 01:00:00
Bid Price Offer Price High Price Low Price Open Price
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Media 0.23 -25.99 -5.14 10
Last Trade Time Trade Type Trade Size Trade Price Currency
- O 0 1.00 GBX

Phorm Corp (PHRM) Latest News

Real-Time news about Phorm Corp (London Stock Exchange): 0 recent articles
More Phorm Corp News
Phorm Corp Takeover Rumours

Phorm Corp (PHRM) Discussions and Chat

Phorm Corp (PHRM) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Phorm Corp trades in real-time

Phorm Corp (PHRM) Top Chat Posts

btcustomer: Phorm are phinally phinished. So much for all those misleading ramps! The cash ran out. The revenues never arrived. The investors finally gave up. Even the CEO is gone - Phorm's phone will be answered by a NY litigator specialising in bankruptcy hearings. Bye. Parting is such sweet sorrow. Must go - I have a bottle of Kent sparkling wine to open! Phorm Corporation Limited Update and Resignation of Nominated Adviser 14/04/2016 9:00am UK Regulatory (RNS & others) Phorm Corp (LSE:PHRM) Historical Stock Chart 1 Month : From Mar 2016 to Apr 2016 Click Here for more Phorm Corp Charts. TIDMPHRM RNS Number : 2041V Phorm Corporation Limited 14 April 2016 14 April 2016 Phorm Corporation Limited ("Phorm" or the "Company") Financial and Operational Update and Resignation of Nominated Adviser Phorm (AIM: PHRM), an advertising-technology company and first party data platform provider, announces that, further to its announcement of 16 March 2016 and extensive discussions with certain of its shareholders and third parties, despite the Company's best efforts in securing financing, it has regrettably been unable to secure the additional equity and/or debt funding required for the group to continue its operational activities. Accordingly, the board of directors of Phorm (the "Board"), having taken appropriate legal advice, is in the process of ceasing the group's trading activities and taking the necessary steps to significantly reduce the group's headcount and overheads. Having commenced an orderly cessation of the group's operations, the Board is mindful that in light of the Company's uncertain financial position, lack of trading activities and absence of any suitable funding, the Board or the Company's major shareholders and/or creditors may, subject to applicable law and restructuring advice, in due course, seek for the Company and/or group affiliated companies to commence appropriate insolvency proceedings, such as administration or liquidation. Regrettably, the Board does not anticipate that shareholders will receive any proceeds in relation to their ordinary shares from any such insolvency proceedings. Accordingly, the Company's nominated adviser, has resigned with immediate effect, resulting in the automatic cancellation of the Company's ordinary shares of nil par value each from trading on the AIM market of the London Stock Exchange plc ("AIM") in 30 days, in accordance with Rule 1 of the AIM Rules for Companies, should the Company not appoint a replacement nominated adviser within that time ("Cancellation"). Pending such Cancellation, the Company's ordinary shares will remain suspended from trading on AIM. The Board notes that the Company's website is currently unavailable due to overdue amounts owed to its supplier of hosting services, which the Company is not currently in a position to satisfy, such that the website is not expected to become available prior to Cancellation. A further announcement(s) will be made by the Company in due course as appropriate. -Ends- For further information please contact: Phorm Corporation Limited Thomas Baylis +1 516-357-3748 This information is provided by RNS The company news service from the London Stock Exchange END MSCIIMPTMBABMJF (END) Dow Jones Newswires April 14, 2016 05:00 ET (09:00 GMT)
btcustomer: So the subscription from 18th Jan FAILED - and the undertakings given by the mysterious sole US investor both then and prior to 1st Feb were worthless - so the lawyers are now charging fees to try and suck out the money. I bet THEY don't get paid in shares! So those with money already sunk into the company, have had to cough up more cash and more loans and convert the earlier loans into yet more shares - otherwise their existing investments of millions of dollars would have evaporated in a bankruptcy. And now we await for the next begging bowl round - £2.5m POUNDS to be raised for more shares, by 24th Feb. I wonder who is going to cough up? Perhaps they need to include some thumb screws in the begging bowl kit? Are there enough gullible investors out there who haven't yet heard of Phorm and who won't expect awkward things like being told the full story of Phorm's inability to earn revenues, or why their R&D cost is so high year after year? On 10th Feb, shares in issue will be 1,050,777,150 - even with the withdrawl of the Jan 18th shares - the dilution continues and continues past the billion mark. And the investors are harder to find each time, and cough up less cash when they are found (or fail to cough up). The only currency Phorm seems to be able to spend is the currency of its own shares, which it prints relentlessly to solve every problem. I do have some questions which I know won't be answered. What on earth went wrong with the Jan 18th subscription? Who WAS this un-named sole US investor who Phorm are now having to sue? Did they even exist? What happened to that investment? Did the investor suddenly run out of money? Did they suddenly discover something they didn't know before? Was this a GENUINE share subscription? Or has something odd happened - to produce the rather convenient and pressurised circumstances where existing investors have been virtually FORCED to cough up loans and further investment, and provide yet another short term cash solution to Phorm's chronic inability to earn revenue, or else sit back and watch the company collapse and their entire shareholding become worthless. It rather reminds me of the missing China £20m share subscription back on the 1st June 2012;symbol=LSE%3APHRM There was lots of hype about the potential of China at the time, even UKTI were dragged into the shouting game, and Phorm's share price went up dramatically - doubling from around 65p to 130p on the back of the announcements and undertakings on China, and the news of that £20m fundraise that never was. Then of course the whole thing folded and the money floated away across the China sea like 20m paper lanterns at a Chinese New Year festival, and the share price plummetted from 130p way down below the original 65p level after the announcement of failure in September 2012 - and eventually, we heard about "operational challenges" in China - and of course - the revenue never ever appeared and the supposed search for alternative sources of funding was abandoned. What on earth is going on, and isn't it time someone had a really good look at the finances and behaviour of this company over the last ten years, including the last few months - under the old board AND the new board? Or is this just what we have to put up with on the AIM cesspit? There sure is a very nasty smell. I think they are reasonable questions. I doubt anyone will provide an answer.
btcustomer: Very low volumes, very significant percentage falls in share price The markets would appear to be getting less eneamoured of Phorm with every week that passes - lowest share price ever, lowest amount raised (and lowest issue price) of share issue ever (£700k at 1.55p).
btcustomer: Great timing for IgbertSponk - his post just depressed the share price a little bit more... A reminder of what his "year ahead" predictions are like: Here's what he said a year ago.... IgbertSponk - 24 Dec 2014 - 10:06:10 - 46529 of 50735 Cash surplus now approaching £3m as massive Crimbo advertising revenues roll in in China. Chinese New Year should see the whole business profitable and Phorm returning to lesser markets like Europe. IgbertSponk - 05 Jan 2015 - 09:26:02 - 46582 of 50735 No comment on this I see biggercapital $PHRM.L is my wtf idea ready to rocket next ROFL - Mr B is still looking for the key to "unlocking the value"... IgbertSponk - 06 Jan 2015 - 09:01:04 - 46613 of 50735 Cash surplus now estimated at £5m as exponential revenues ramp up. A lot of this will be reinvested in new China Telecom projects, so we'll have to wait for the maiden divi. Phorm begged another £17.5m during 2015 - IgbertSponk got that wrong then... and China phizzled out with "operational challenges" - so another IgbertSponk misfire... He's not very good at this is he? The year actually went like this... I can't find any poster called BTSaddoe - you really need to up your game IgbertSponk, maybe it's your lack of precision on details that sends your Phorm share price predictions so far astray? 23.53% down today so far... and no more good news - no revaluation of director's options - no "SomecompanyWejustMadeUpToday Media" announced as a new "partner"? No Russian DPI trial with Изв;есm0;ия, or Мос;коk4;ск 80;е нов;осm0;и, or Ком;меl8;са 85;тъ ? No announcement that the BOD will be paying £2m/mth for the privelige of serving? Why not just make a public announcement of a deal with GCHQ and NSA to provide DPI services to the secret squirrels under the Snoopers Charter for the next ten years? That would boost public confidence no end - after all - security is here to stay. Or might the idea of Phorm kit from Russia/China protecting the national infrastructure bring back unhappy memories of those internet outages in Korea, Romania, Brazil and Turkey that always seemed to happen around the time the Phorm DPI kit was being deployed? At the current price, a £2m share issue would require 123m new shares, a 12% dilution. And then they'd have to do it all over again... Unless of course, the revenue is flowing in an unprecedented manner? Anyone seen the 2015 revenue figures?
btcustomer: Viollette Company Limited hold around 224m shares in Phorm according to the Phorm company website. hTtp:// (whoever Viollette might belong to, which has always been something of a mystery as far as the general public are concerned) At the time Ertugrul & Croxson left Phorm, on 15th July, Viollette's shareholding was worth 25% at a share price of around 3p On 12th August Viollette's share of the company was diluted from 25% to 22.88%. at a share price of around 8.2p On 6 November they participated in the next cash bailout, taking their share to 22.3% at a price of around 3.375p - interestingly, although they bought new shares they still ended up owning less of the company than is declared from the 12th August AIM 26 declaration, because their stock was diluted by the new shares issued to other parties. There has been no update of the AIM 26 declaration since 12th August, despite the 6th November bailout, so the percentages stated there are incorrect, in relation to today's valuations. As of close of business today, Viollette's 22.3% share of the company was worth £4,110,168 The mystery guest who owns Viollette has lost a shedload of cash. They also have loan notes worth £0.975m which they can convert into shares, although maybe right now that isn't an attractive proposition (unless they know something the rest of us don't). But several years worth of emoluments might make up for it. Still - as long as its all kosher - and we are assured that it was, by both Phorm and those excellent brokers Strand Hanson, on 6th November... the directors of Phorm consider, having consulted with Strand Hanson Limited, that the terms of Viollette and Meditor's participations in the Placing are fair and reasonable insofar as the Company's shareholders are concerned. But this is the AIM cess pit... so who knows what it all means?
btcustomer: You are LYING again IgbertSponk. Your lie is, "Good to see you still think the £500 a share price achievable BTC." I don't think the £500 a share price is achievable. And have never said so. How long is it since these shares were even £5 let alone dreaming of £500? It was in mid June 2009 - at the time Phorm were spinning yarns about tremendously exciting new markets in Korea, and also announcing "Webwise Discover, the ultimate recommendation engine". Oh yes - and having just gone to the markets for $24m at £4.50 a share on 10th June. (after which the shares promptly crashed to £1 and of course, Korea fizzled out - (although we are still waiting for the Korea markets update in due course). How long do we have to "HOVER" around waiting for some action?
btcustomer: Another day with the share price sliding - 4.55% this time. Mr Bigger's 25.4m PHRM shares are now down to a total value of £666,750 compared to the approximately £2.02m he paid for them. They clearly now occupy the "tax mitigation" section of his portfolio and will no doubt perform well in that capacity. I see also that the "spend" figure for Phorm since 2003, based on the latest accurate figures published by Phorm itself, has now gone over $400m. Can anyone make me a rational case for this share being a multi-bagger investment? The case Bigger made over a year ago has been effectively trashed, not only by the fact that he (with Phorm management as the source) got his revenue predictions badly wrong (more than once), but also by Phorm's subsequent withdrawal from Turkey and China, and their continuing lack of cash. Since 2003... Spent - >$400m Directors' emoluments - >$13.589m Loan liabilities - >$3.778m Available cash - >Minus $2m Revenues earned during H2 2015? I doubt we'll be told much about THAT. Did PhluidMedia manage to decide who their Chief Revenue Officer is? Is it Flash Gordon (Lou Severin from New York) hTtps:// "Chief Revenue Officer - PhluidMedia" or David Paquette from Boston? hTtp:// Phorm.... is pleased to announce that it has hired Mr David Paquette as Chief Revenue Officer Who seems to have been hired as CRO of PHORM, but advertising himself as CRO of PhluidMedia.. hTtps:// Chief Revenue Officer at Phluid Media Company Or do they still have enough cash to pay the salaries of TWO CROs? Or is one of them CRO for TWO companies, one a wholly owned subsidiary of the other? Or are the Phorm/PhluidMedia corporate announcements simply as confused as they always have been? And when will Phorm be updating shareholders about their acquisition/control of Russian company iMarker and the transfer of US/UK consumer and browsing data to Russian servers at Of course, Phorm don't have to tell us any of this. They can keep shtum and watch the share price and company bank balance disappear over the horizon like a Chinese MOU, a Turkish BTK fine, or a Korea markets update.
btcustomer: What they doing inside? The weather's been lovely. They should be outside, picking APPLES. Price down on the week. Another great week for Phorm PR. Someone should have a word with Mr Bigger, his recent tweets suggest he doesn't understand the legal implications of Phorm's model in either the EU or the USA. All will be revealed. Dilution or suspension. As for "who can buy" shares... according to Phorm, the main investors currently are: Meditor Capital Management Limited 24.04% Viollette Company Limited 22.88% FiveT Investment Management Limited 9.09% The Capital Group Companies, Inc. 7.99% Hargreave Hale 4.57% Standard Life Investments Limited 3.27% and they state that: In accordance with the AIM Rules for Companies, as of 12 August 2015, in so far as the Company is aware, the percentage of issued share capital that was ‘not in public hands’ was 56.06%. which leaves nearly 260m shares that the large investors named above DON'T own, and leaves over 405m shares "in public hands". Strange - I don't see a queue of "tremendously excited" investors queueing up to buy them and driving the share price up. So "who can buy?" asks sparky87. Answer: LOTS of people, and there are over 400m shares for them to fight over. Where have they all GONE these last few weeks? But of course we must bow to the superior knowledge of sparky87. He made that hot prediction on 14th August when the share price was around 8p. sparky87 14 Aug'15 - 10:52 - 347 of 348 Market starting to realise new board my deliver on all the things Kent could not, exciting times ahead I await news. Well - we got the news on 30th September, when we learned that "the revenues had failed to materialize". It was lousy news. The share price reacted accordingly, as did the volumes. Not only is the cash tin empty (according to Phorm), but so is the PR armoury. All Phorm were able to give us was a badly handled out of date recycled job appointment with sloppy background paperwork/admin.
btcustomer: sparky87 6 Sep'15 - 10:07 - 49589 of 49591 Btcustomer. Your talking twaddle. Phorm's technology has moved on massively from what you understand. Your living in the past, I believe investors are looking forward to where this company is going under the new management. Golly - it IS busy here this weekend. Worried? So the pitch given to the large advertising agencies in Moscow in November 2014 was about "the past" then? (and the Russian revenue is what the company are relying on right now, such as it is). This wonderful new "pre-bid solution algorithm" is NEW stuff? Unique new stuff that no one else can do? Wow!! The share price will soar then, and the revenues will be pouring in? hxxp:// Our algorithm analyzes over 2 Billion data points or unique characteristics in real-time – with the goal of finding that perfect match or connection – try saying that 3 times in a row. Okay then... Our algorithm analyzes over 2 Billion data points or unique characteristics in real-time – with the goal of finding that perfect match or connectionOur algorithm analyzes over 2 Billion data points or unique characteristics in real-time – with the goal of finding that perfect match or connectionOur algorithm analyzes over 2 Billion data points or unique characteristics in real-time – with the goal of finding that perfect match or connection Despite the massive shift in public sentiment about ad blocking? Despite Apple's moves to introduce mobile ad blocking in iOS? Despite the awareness by consumers of the crippling waste of bandwidth caused by ads (which they have to pay for)? htTps:// Despite the presence of many large profitable competitors in an overcrowded market, who have proved themselves in a market that Phorm has FAILED in repeatedly? Well, this WILL be interesting... Or of course, it may just be the incredibly tedious "same old.." of ramping, fake good news - share price slight rise - share issue - share price fall - revelations about failed markets and disappointing revenues - ramping - fake good news - share price slight rise - share issue - share price fall - revelations about failed markets and disappointing revenues - ramping - fake good news - repeat "ad" nauseam. Perhaps sparky87 could give us some EVIDENCE about this new technology? Starting perhaps with the details of the (granted) international PATENTS for this wizard new tech? (patents are publicly available information - so no reasons not to share it). If you haven't even got the PATENT information for this PhD Methodology, I'll assume you are simply ramping/bluffing. If anyone wants a laugh, and a lesson in how to produce a website full of meaningless marketspeak, they could visit hxxp:// - it's a masterpiece of obfuscation. And it sets covert Russian cookies just for fun. And it only took four superheroes (and a new board) to get it going, Flash Gordon, Iron Man, Superman, She-Ra Warrior - although they don't seem much better at corporate compliance than the old team judging by felixcatuk's post above. Thing is dear rampers, you've spent the last few years telling us the OLD team was fantastic. Now you are extolling the virtues of their replacements. Forgive us for not falling over in a swoon and believing you. Because of the covert cookies from that get set if you visit I've left those links unclickable. By the way, talking about iMarker, how's the switch from Oracle to PostgreSQL going? hTtp:// "4 ГОД;А!?" sounds a bit depressing.
btcustomer: The share price is 3.33% DOWN on the day. Bigger bought in at 9p Roth bought in at 10.5p & 9.5p & 11p April fundraising was at 8p When the FYRs were published, the share price was 4.5p When they appointed Mr Alkin, the share price was about 2.2p When they gave Ertugrul and Croxson their marching orders "with immediate effect" the share price was 3p. The entire "recovery" since the new low of 2nd July has been to the dizzy heights of only 3.625p. Which still leaves Mr Roth, and Mr Bigger substantially out of pocket. And they still currently need millions of dollars worth of cash (don't they always?).
Phorm Corp share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Phorm Corp
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200926 06:49:27